Montana Aerospace Valuation
Is 0AAI undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
5/6Valuation Score 5/6
Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of 0AAI when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: 0AAI (CHF20.3) is trading below our estimate of fair value (CHF44.66)
Significantly Below Fair Value: 0AAI is trading below fair value by more than 20%.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for 0AAI?
Other financial metrics that can be useful for relative valuation.
| What is 0AAI's n/a Ratio? | |
|---|---|
| n/a | 0x |
| n/a | n/a |
| Market Cap | €1.33b |
| Key Statistics | |
|---|---|
| Enterprise Value/Revenue | 1x |
| Enterprise Value/EBITDA | 11.5x |
| PEG Ratio | n/a |
Price to Sales Ratio vs Peers
How does 0AAI's PS Ratio compare to its peers?
| Company | Forward PS | Estimated Growth | Market Cap |
|---|---|---|---|
| Peer Average | 1.1x | ||
CHG Chemring Group | 2.1x | 9.3% | UK£1.0b |
SNR Senior | 0.6x | 6.5% | UK£626.4m |
QQ. QinetiQ Group | 1.3x | 6.4% | UK£2.5b |
BAB Babcock International Group | 0.6x | 4.0% | UK£2.4b |
0AAI Montana Aerospace | 0.9x | 7.4% | CHF 1.2b |
Price-To-Sales vs Peers: 0AAI is good value based on its Price-To-Sales Ratio (0.9x) compared to the peer average (1.1x).
Price to Earnings Ratio vs Industry
How does 0AAI's PE Ratio compare vs other companies in the European Aerospace & Defense Industry?
Price-To-Sales vs Industry: 0AAI is good value based on its Price-To-Sales Ratio (0.9x) compared to the European Aerospace & Defense industry average (1.6x).
Price to Sales Ratio vs Fair Ratio
What is 0AAI's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
| Fair Ratio | |
|---|---|
| Current PS Ratio | 0.9x |
| Fair PS Ratio | 1.3x |
Price-To-Sales vs Fair Ratio: 0AAI is good value based on its Price-To-Sales Ratio (0.9x) compared to the estimated Fair Price-To-Sales Ratio (1.3x).
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
| Date | Share Price | Average 1Y Price Target | Dispersion | High | Low | 1Y Actual price | Analysts |
|---|---|---|---|---|---|---|---|
| Current | CHF 20.30 | CHF 24.31 +19.8% | 20.6% | CHF 31.72 | CHF 18.27 | n/a | 5 |
| Sep ’25 | CHF 19.12 | CHF 24.40 +27.6% | 20.6% | CHF 31.92 | CHF 18.39 | n/a | 5 |
| Aug ’25 | CHF 18.70 | CHF 24.16 +29.2% | 20.4% | CHF 32.03 | CHF 17.79 | n/a | 5 |
| Jul ’25 | CHF 19.10 | CHF 23.67 +23.9% | 20.7% | CHF 31.54 | CHF 17.36 | n/a | 5 |
| Jun ’25 | CHF 19.60 | CHF 23.22 +18.5% | 22.1% | CHF 32.04 | CHF 17.83 | n/a | 5 |
| May ’25 | CHF 17.76 | CHF 21.92 +23.4% | 23.5% | CHF 32.05 | CHF 17.79 | n/a | 5 |
| Apr ’25 | CHF 16.90 | CHF 22.33 +32.1% | 26.9% | CHF 32.07 | CHF 15.22 | n/a | 5 |
| Mar ’25 | CHF 15.48 | CHF 22.33 +44.3% | 26.9% | CHF 32.07 | CHF 15.22 | n/a | 5 |
| Feb ’25 | CHF 16.92 | CHF 22.42 +32.5% | 27.1% | CHF 31.99 | CHF 15.18 | n/a | 5 |
| Jan ’25 | CHF 17.66 | CHF 22.59 +27.9% | 28.8% | CHF 33.02 | CHF 14.96 | n/a | 5 |
| Dec ’24 | CHF 15.70 | CHF 22.05 +40.5% | 27.2% | CHF 33.01 | CHF 15.32 | n/a | 5 |
| Nov ’24 | CHF 11.50 | CHF 21.85 +90.0% | 27.5% | CHF 31.64 | CHF 15.32 | n/a | 4 |
| Oct ’24 | CHF 11.26 | CHF 22.25 +97.6% | 28.0% | CHF 32.34 | CHF 15.30 | n/a | 4 |
| Sep ’24 | CHF 13.60 | CHF 24.76 +82.1% | 19.2% | CHF 31.88 | CHF 19.92 | CHF 19.12 | 4 |
| Aug ’24 | CHF 13.70 | CHF 24.97 +82.3% | 18.7% | CHF 31.74 | CHF 19.49 | CHF 18.70 | 4 |
| Jul ’24 | CHF 14.44 | CHF 24.97 +72.9% | 18.7% | CHF 31.74 | CHF 19.49 | CHF 19.10 | 4 |
| Jun ’24 | CHF 14.06 | CHF 26.16 +86.0% | 19.3% | CHF 31.97 | CHF 19.63 | CHF 19.60 | 3 |
| May ’24 | CHF 16.45 | CHF 26.40 +60.5% | 18.7% | CHF 31.93 | CHF 19.96 | CHF 17.76 | 3 |
| Apr ’24 | CHF 14.94 | CHF 26.48 +77.3% | 18.8% | CHF 32.12 | CHF 20.01 | CHF 16.90 | 3 |
| Mar ’24 | CHF 17.46 | CHF 26.38 +51.1% | 18.7% | CHF 31.97 | CHF 19.98 | CHF 15.48 | 3 |
| Feb ’24 | CHF 16.94 | CHF 26.25 +55.0% | 23.8% | CHF 32.51 | CHF 20.00 | CHF 16.92 | 2 |
| Jan ’24 | CHF 14.34 | CHF 28.77 +100.6% | 24.4% | CHF 35.22 | CHF 19.03 | CHF 17.66 | 3 |
| Dec ’23 | CHF 13.38 | CHF 28.77 +115.0% | 24.4% | CHF 35.22 | CHF 19.03 | CHF 15.70 | 3 |
| Nov ’23 | CHF 11.56 | CHF 30.45 +163.3% | 26.7% | CHF 37.09 | CHF 19.02 | CHF 11.50 | 3 |
| Oct ’23 | CHF 10.34 | CHF 33.43 +223.4% | 10.4% | CHF 36.92 | CHF 28.71 | CHF 11.26 | 3 |
| Sep ’23 | CHF 14.66 | CHF 33.43 +128.0% | 10.4% | CHF 36.92 | CHF 28.71 | CHF 13.60 | 3 |
Analyst Forecast: Target price is more than 20% higher than the current share price, but analysts are not within a statistically confident range of agreement.